"Therapy with EBV-specific CTLs (cytotoxic lymphocytes) was effective for these patients who were severely immune-compromised, as the cells successfully reached the tumor, multiplied and were able to kill tumor cells" said Dr. Helen Heslop, lead author of the study and professor of pediatrics and medicine and a member of the Center for Cell and Gene therapy at BCM, The Methodist Hospital and Texas Children's. The cell remained in the body for up to nine years, providing long-term protection.
Patients who undergo the transplants are often immune-suppressed. Because most people have been infected with Epstein-Barr virus, the lack of immune protection makes their lymph system vulnerable to adverse effects of the virus, especially lymphomas that can be traced directly back to the infection.
In this study, 114 patients who had received hematopoietic or blood-related stem cell transplants from an unrelated donor or a family member whose bone marrow was not a perfect match also received infusions of immune components called T-cells that were design to target Epstein-Barr virus-infected cells. The treatment was preventive in 101 patients, none of whom developed lymphomas associated with Epstein-Barr virus infection. Eleven of 13 patients who had this disease or symptoms of it had sustained remissions.
Because the cells were marked, researchers determined that the special cells remained in the body for as long as nine years. The cost of the therapy, which spares normal cells, was estimated at just over $6,000, which compares favorably to other treatments for the disorder.
Researchers infused the cells soon after the patients received the stem cell transplants, which could account for its success, said Heslop and her colleagues.
"With such a promising therapy, it's important that it is not only effective, but that it is a cost-effective option for high-risk patients," said Heslop.
Others who took part in this research include Martin A Pule, Alexandra Rousseau, Catherine M Bollard, Malcolm K Brenner and Cliona M Rooney, all of the Center for Cell and Gene Therapy at BCM, Methodist and Texas Children's; Hao Liu and Meng-Fen Wu of the Dan L. Duncan Cancer Center at BCM, Karen S. Slobod of Novartis Vaccine & Diagnostics in Cambridge, Mass.; ,Gregory A Hale, Colton A Smith, Richard J Rochester and Julia L Hurwitz of St. Jude Children's Research Hospital in Memphis, Tenn. and Persis J Amrolia of Great Ormond St. Children's Hospital in London, UK.
Funding for this work came from the National Institutes of Health, the Leukemia and Lymphoma Society, the National Cancer Institute, the Assisi Foundation and the American Lebanese Syrian Associated Charities.
'Icebreaker' protein opens genome for t cell development, Penn researchers find
21.02.2018 | University of Pennsylvania School of Medicine
Similarities found in cancer initiation in kidney, liver, stomach, pancreas
21.02.2018 | Washington University School of Medicine
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.
But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...
Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.
The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...
Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters
Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
21.02.2018 | Life Sciences
21.02.2018 | Life Sciences
21.02.2018 | Materials Sciences